R
Richard Lewanczuk
Researcher at Alberta Health Services
Publications - 196
Citations - 9110
Richard Lewanczuk is an academic researcher from Alberta Health Services. The author has contributed to research in topics: Blood pressure & Health care. The author has an hindex of 47, co-authored 190 publications receiving 8105 citations. Previous affiliations of Richard Lewanczuk include University of Alberta & University of Hong Kong.
Papers
More filters
Journal ArticleDOI
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
Kaberi Dasgupta,Robert R. Quinn,Kelly B. Zarnke,Doreen M. Rabi,Pietro Ravani,Stella S. Daskalopoulou,Simon W. Rabkin,Luc Trudeau,Ross D. Feldman,Lyne Cloutier,Ally P.H. Prebtani,Robert J. Herman,Simon L. Bacon,Richard E. Gilbert,Marcel Ruzicka,Donald W. McKay,Tavis S. Campbell,Steven A. Grover,George Honos,Ernesto L. Schiffrin,Peter Bolli,Thomas W. Wilson,Patrice Lindsay,Michael D. Hill,Shelagh B. Coutts,Gord Gubitz,Mark Gelfer,Michel Vallée,G. V. Ramesh Prasad,Marcel Lebel,Donna McLean,J. Malcolm O. Arnold,Gordon W. Moe,Jonathan G. Howlett,Jean-Martin Boulanger,Pierre Larochelle,Lawrence A. Leiter,Charlotte Jones,Richard I. Ogilvie,Vincent Woo,Janusz Kaczorowski,Kevin D. Burns,Robert J. Petrella,Swapnil Hiremath,Alain Milot,James A. Stone,Denis Drouin,Kim L. Lavoie,Maxime Lamarre-Cliche,Guy Tremblay,Pavel Hamet,George Fodor,S. George Carruthers,George Pylypchuk,Ellen Burgess,Richard Lewanczuk,George K. Dresser,S. Brian Penner,Robert A. Hegele,Philip A. McFarlane,Milan Khara,Andrew L. Pipe,Paul Oh,Peter Selby,Mukul Sharma,Debra Reid,Sheldon W. Tobe,Raj Padwal,Luc Poirier +68 more
TL;DR: The Canadian Hypertension Education Program reviews the hypertension literature annually and provides detailed recommendations regarding hypertension diagnosis, assessment, prevention, and treatment, and 4 new recommendations were added and 2 existing recommendations were modified this year.
Journal ArticleDOI
Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children
Kara Nerenberg,Kelly B. Zarnke,Alexander A. Leung,Kaberi Dasgupta,Sonia Butalia,Kerry McBrien,Kevin C. Harris,Meranda Nakhla,Lyne Cloutier,Mark Gelfer,Maxime Lamarre-Cliche,Alain Milot,Peter Bolli,Guy Tremblay,Donna McLean,Raj Padwal,Karen C. Tran,Steven A. Grover,Simon W. Rabkin,Gordon W. Moe,Jonathan G. Howlett,Patrice Lindsay,Michael D. Hill,Mike Sharma,Thalia S. Field,Theodore Wein,Ashkan Shoamanesh,George K. Dresser,Pavel Hamet,Robert J. Herman,Ellen Burgess,Steven E. Gryn,Jean Grégoire,Richard Lewanczuk,Luc Poirier,Tavis S. Campbell,Ross D. Feldman,Kim L. Lavoie,Ross T. Tsuyuki,George Honos,Ally P.H. Prebtani,Gregory A. Kline,Ernesto L. Schiffrin,Andrew C. Don-Wauchope,Sheldon W. Tobe,Richard E. Gilbert,Lawrence A. Leiter,Charlotte Jones,Vincent Woo,Robert A. Hegele,Peter Selby,Andrew L. Pipe,Philip A. McFarlane,Paul Oh,Milan Gupta,Simon L. Bacon,Janusz Kaczorowski,Luc Trudeau,Norman R.C. Campbell,Swapnil Hiremath,Michael Roerecke,JoAnne Arcand,Marcel Ruzicka,G. V. Ramesh Prasad,Michel Vallée,Cedric Edwards,Praveena Sivapalan,S. Brian Penner,Anne Fournier,Geneviève Benoit,Janusz Feber,Janis M. Dionne,Laura A. Magee,Alexander G. Logan,Anne-Marie Côté,Evelyne Rey,Tabassum Firoz,Laura M. Kuyper,Jonathan Y. Gabor,Raymond R. Townsend,Doreen M. Rabi,Doreen M. Rabi,Stella S. Daskalopoulou +82 more
TL;DR: All individuals with hypertension should have an assessment of global cardiovascular risk to promote health behaviours that lower blood pressure, and an angiotensin receptor-neprilysin inhibitor combination should be used in place of either an ang Elliotensin-converting enzyme inhibitor or angiotENSin receptor blocker in individuals with heart failure.
Journal ArticleDOI
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
Alexander A. Leung,Kara Nerenberg,Stella S. Daskalopoulou,Kerry McBrien,Kelly B. Zarnke,Kaberi Dasgupta,Lyne Cloutier,Mark Gelfer,Maxime Lamarre-Cliche,Alain Milot,Peter Bolli,Guy Tremblay,Donna McLean,Sheldon W. Tobe,Marcel Ruzicka,Kevin D. Burns,Michel Vallée,G. V. Ramesh Prasad,Marcel Lebel,Ross D. Feldman,Peter Selby,Andrew L. Pipe,Ernesto L. Schiffrin,Philip A. McFarlane,Paul Oh,Robert A. Hegele,Milan Khara,Thomas W. Wilson,S. Brian Penner,Ellen Burgess,Robert J. Herman,Simon L. Bacon,Simon W. Rabkin,Richard E. Gilbert,Tavis S. Campbell,Steven A. Grover,George Honos,Patrice Lindsay,Michael D. Hill,Shelagh B. Coutts,Gord Gubitz,Norman R.C. Campbell,Gordon W. Moe,Jonathan G. Howlett,Jean-Martin Boulanger,Ally P.H. Prebtani,Pierre Larochelle,Lawrence A. Leiter,Charlotte Jones,Richard I. Ogilvie,Vincent Woo,Janusz Kaczorowski,Luc Trudeau,Robert J. Petrella,Swapnil Hiremath,Denis Drouin,Kim L. Lavoie,Pavel Hamet,George Fodor,Jean Grégoire,Richard Lewanczuk,George K. Dresser,Mukul Sharma,Debra Reid,Scott A. Lear,Gregory Moullec,Milan Gupta,Milan Gupta,Laura A. Magee,Alexander G. Logan,Kevin C. Harris,Janis M. Dionne,Anne Fournier,Geneviève Benoit,Janusz Feber,Luc Poirier,Raj Padwal,Doreen M. Rabi +77 more
TL;DR: In the diagnosis and assessment of hypertension, automated office blood pressure, taken without patient-health provider interaction, is now recommended as the preferred method of measuring in-office blood pressure as mentioned in this paper.
Patent
Method of using deuterated calcium channel blockers
TL;DR: In this article, a method of enhancing the efficiency and increasing the duration of action of drugs (e.g., dihydropyridines and anti-bacterials) and particularly of nifedipine and penicillins wherein one or more hydrogen atoms are deuterated was presented.
Journal ArticleDOI
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.
Doreen M. Rabi,Kerry McBrien,Ruth Sapir-Pichhadze,Meranda Nakhla,Sofia B. Ahmed,Sandra M. Dumanski,Sonia Butalia,Alexander A. Leung,Kevin C. Harris,Lyne Cloutier,Kelly B. Zarnke,Marcel Ruzicka,Swapnil Hiremath,Ross D. Feldman,Sheldon W. Tobe,Tavis S. Campbell,Simon L. Bacon,Kara Nerenberg,George K. Dresser,Anne Fournier,Ellen Burgess,Patrice Lindsay,Simon W. Rabkin,Ally P.H. Prebtani,Steven A. Grover,George Honos,Jeffrey E. Alfonsi,JoAnne Arcand,François Audibert,Geneviève Benoit,Jesse Bittman,Peter Bolli,Anne-Marie Côté,Janis M. Dionne,Andrew C. Don-Wauchope,Cedric Edwards,Tabassum Firoz,Jonathan Y. Gabor,Richard E. Gilbert,Jean Grégoire,Steven E. Gryn,Milan Gupta,Fady Hannah-Shmouni,Robert A. Hegele,Robert J. Herman,Michael D. Hill,Jonathan G. Howlett,Gregory L. Hundemer,Charlotte Jones,Janusz Kaczorowski,Nadia A. Khan,Laura M. Kuyper,Maxime Lamarre-Cliche,Kim L. Lavoie,Lawrence A. Leiter,Richard Lewanczuk,Alexander G. Logan,Laura A. Magee,Birinder K. Mangat,Philip A. McFarlane,Donna McLean,André Michaud,Alain Milot,Gordon W. Moe,S. Brian Penner,Andrew L. Pipe,Alexandre Y Poppe,Evelyne Rey,Michael Roerecke,Ernesto L. Schiffrin,Peter Selby,Mike Sharma,Ashkan Shoamanesh,Praveena Sivapalan,Raymond R. Townsend,Karen Tran,Luc Trudeau,Ross T. Tsuyuki,Michel Vallée,Vincent Woo,Alan Bell,Stella S. Daskalopoulou +81 more
TL;DR: The 2020 guidelines include new guidance on themanagement of resistant hypertension and the management of hypertension in women planning pregnancy.